Plasma phosphorylated tau181 predicts cognitive and functional decline.
Thomas Francis TropeaTeresa WaligorskaSharon X XieIlya M NasrallahKatheryn Alexandra Quilico CousinsJohn Q TrojanowskiMurray GrossmanDavid John IrwinDaniel WeintraubEdward B LeeDavid A WolkAlice S Chen-PlotkinLeslie M Shawnull nullPublished in: Annals of clinical and translational neurology (2022)
Plasma p-tau181 differentiates AD pathology cases from NC with high accuracy. Higher levels of plasma p-tau181 are associated with faster cognitive and functional decline.
Keyphrases